Tareq Abadl: Massive Transfusion – The Hidden Citrate Risk
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Did you know that during massive transfusion, one hidden danger is not the blood type – but the anticoagulant inside the blood bag?
Blood components are stored with citrate to prevent clotting.
During massive transfusion, large amounts of citrate can bind calcium and magnesium in the patient’s bloodstream, leading to citrate toxicity and hypocalcemia.
Why does this matter?
Because calcium is critical for:
- Cardiac contractility
- Coagulation pathways
- Neuromuscular function
- Cellular stability.
When citrate accumulates faster than the body can metabolize it, patients may develop:
- Hypotension
- Reduced ventricular function
- Arrhythmias
- Coagulopathy
- Tetany or increased neuromuscular excitability.
Under normal conditions, citrate is rapidly metabolized through the Krebs cycle, mainly by the liver, kidneys, and skeletal muscle. But in trauma, shock, hypothermia, liver dysfunction, or poor tissue perfusion, citrate clearance decreases significantly – making toxicity more likely during rapid transfusion.
An important point in transfusion medicine:
- Hypocalcemia in massive transfusion is often dilutional and citrate-related at the same time.
That is why modern Massive Transfusion Protocols (MTPs) emphasize:
- Monitoring ionized calcium
- Early calcium replacement
- Close assessment of coagulation and electrolytes
Prevention of the ‘lethal triad’:
- Hypothermia
- Coagulopathy
- Acidosis.
Another interesting blood bank fact:
- Plasma and platelets usually contain more citrate than packed RBCs, so the risk may increase when large amounts of these components are transfused rapidly.
This is a powerful reminder that transfusion safety is not only about ABO and Rh compatibility.
Blood bank science also involves understanding metabolic, electrolyte, and coagulation complications during emergency transfusion support.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers